Gain Therapeutics, Inc.
GANX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001819411
No open-market purchases or sales by Gain Therapeutics, Inc. insiders were filed in the last 90 days; 50 institutions reported holding it in 13F filings for Q2 2026, worth $17.4M in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q1 2025
Institutional positions in Gain Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 33
- +8 vs. Q4 2024
- Shares held
- 2.81M
- +827.1K (+41.7%) vs. Q4 2024
- Total value
- $5.07M
- +$1.12M (+28.5%) vs. Q4 2024
- New holders
- 10
- 12 more added
- Sold out
- 2
- 2 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GANX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 50 | $17.4M |
| Q1 2026 | 42 | $15.8M |
| Q4 2025 | 48 | $25.9M |
| Q3 2025 | 38 | $7.70M |
| Q2 2025 | 35 | $6.49M |
| Q1 2025 | 33 | $5.07M |
| Q4 2024 | 25 | $3.94M |
| Q3 2024 | 19 | $2.40M |
| Q2 2024 | 28 | $3.89M |
| Q1 2024 | 26 | $7.04M |
| Q4 2023 | 24 | $5.05M |
| Q3 2023 | 24 | $4.95M |
| Q2 2023 | 24 | $5.68M |
| Q1 2023 | 22 | $5.54M |
| Q4 2022 | 21 | $3.78M |
| Q3 2022 | 23 | $3.95M |
| Q2 2022 | 16 | $3.87M |
| Q1 2022 | 16 | $4.75M |
| Q4 2021 | 19 | $5.71M |
| Q3 2021 | 14 | $6.65M |
| Q2 2021 | 14 | $8.95M |
| Q1 2021 | 12 | $15.0M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Gain Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DME Capital Management, LPSuperinvestorGreenlight Capital | 566,130 | $1.08M | 0.05% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 427,700 | $808.4K | 0.00% | +329,450+335.3% | Added |
| Geode Capital Management, LLC | 282,211 | $539.1K | 0.00% | +14,790+5.5% | Added |
| Vanguard Group Inc | 254,990 | $487.0K | 0.00% | +77,915+44.0% | Added |
| Marshall Wace, LLP | 196,026 | $374.4K | 0.00% | +104,288+113.7% | Added |
| Dauntless Investment Group, LLC | 125,584 | $239.9K | 0.89% | +125,584 | New |
| Northern Trust Corp | 100,170 | $191.3K | 0.00% | +15,584+18.4% | Added |
| Morgan Stanley | 99,795 | $190.6K | 0.00% | +11,283+12.7% | Added |
| Susquehanna International Group, LLP | 85,958 | $164.2K | 0.00% | +39,045+83.2% | Added |
| BlackRock, Inc. | 84,407 | $161.2K | 0.00% | −1,654−1.9% | Reduced |
| State Street Corp | 71,137 | $135.9K | 0.00% | 00.0% | Unchanged |
| Cambridge Investment Research Advisors, Inc. | 59,500 | $114.0K | 0.00% | +5,000+9.2% | Added |
| Kovitz Investment Group Partners, LLC | 47,578 | $90.9K | 0.00% | +47,578 | New |
| UBS Group AG | 43,360 | $82.8K | 0.00% | +8,133+23.1% | Added |
| Prelude Capital Management, LLC | 35,820 | $68.4K | 0.01% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 30,004 | $57.3K | 0.00% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 20,154 | $38.3K | 0.00% | +20,154 | New |
| Citadel Advisors LLC | 19,019 | $36.3K | 0.00% | +7,407+63.8% | Added |
| Benedict Financial Advisors Inc | 18,000 | $34.4K | 0.01% | +2,000+12.5% | Added |
| Sandhill Capital Partners LLC | 15,400 | $29.4K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 14,355 | $27.4K | 0.00% | +14,355 | New |
| Sprott Inc. | 14,000 | $26.7K | 0.00% | 00.0% | Unchanged |
| Armis Advisers, LLC | 10,750 | $22.0K | 0.00% | +10,750 | New |
| GWM Advisors LLC | 10,600 | $20.2K | 0.00% | +10,600 | New |
| Creekmur Asset Management LLC | 4,440 | $8.48K | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 4,410 | $8.42K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,102 | $7.83K | 0.00% | +17+0.4% | Added |
| Simplex Trading, LLC | 3,444 | $6.00K | 0.00% | +3,444 | New |
| Wells Fargo & Company | 2,650 | $5.06K | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 2,500 | $4.78K | 0.00% | +2,500 | New |
| Tower Research Capital LLC (TRC) | 2,432 | $4.64K | 0.00% | +2,432 | New |
| FMR LLC | 80 | $154 | 0.00% | +80 | New |
| Gotham Asset Management, LLC | 153,984 | – | – | −4,171−2.6% | Reduced |
| Royal Bank of Canada | 0 | $0 | 0.00% | −17,500−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |